Literature DB >> 10095777

Isolation of the CXC chemokines ENA-78, GRO alpha and GRO gamma from tumor cells and leukocytes reveals NH2-terminal heterogeneity. Functional comparison of different natural isoforms.

A Wuyts1, C Govaerts, S Struyf, J P Lenaerts, W Put, R Conings, P Proost, J Van Damme.   

Abstract

Chemokines are a family of chemotactic peptides affecting leukocyte migration during the inflammatory response. Post-translational modification of chemokines has been shown to affect their biological potency. Here, the isolation and identification of natural isoforms of the neutrophil chemoattractants GRO alpha and GRO gamma and the epithelial-cell-derived neutrophil attractant-78 (ENA-78), is reported. Cultured tumor cells produced predominantly intact chemokine forms, whereas peripheral blood monocytes secreted mainly NH2-terminally truncated forms. The order of neutrophil chemotactic potency of these CXC chemokines was GRO alpha > GRO gamma > ENA-78 both for intact and truncated forms. However, truncated GRO alpha (4,5,6-73), GRO gamma (5-73) and ENA-78(8,9-78) were 30-fold, fivefold and threefold more active than the corresponding intact chemokine. As a consequence, truncated GRO alpha (4,5,6-73) was 300-fold more potent than intact ENA-78 indicating that both the type of chemokine and its mode of processing determine the chemotactic potency. Similar observations were made when intact and truncated GRO alpha, GRO gamma and ENA-78 were compared for their capacity to induce an increase in the intracellular calcium concentration in neutrophilic granulocytes, and to desensitize the calcium response towards the CXC chemokine granulocyte chemotactic protein-2 (GCP-2). It must be concluded that physiological proteolytic cleavage of CXC chemokines in general enhances the inflammatory response, whereas for CC chemokines NH2-terminal processing mostly results in reduced chemotactic potency.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10095777     DOI: 10.1046/j.1432-1327.1999.00166.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  18 in total

1.  Cysteine Cathepsins Activate ELR Chemokines and Inactivate Non-ELR Chemokines.

Authors:  Urska Repnik; Amanda E Starr; Christopher M Overall; Boris Turk
Journal:  J Biol Chem       Date:  2015-04-01       Impact factor: 5.157

2.  A streptococcal protease that degrades CXC chemokines and impairs bacterial clearance from infected tissues.

Authors:  Carlos Hidalgo-Grass; Inbal Mishalian; Mary Dan-Goor; Ilia Belotserkovsky; Yoni Eran; Victor Nizet; Amnon Peled; Emanuel Hanski
Journal:  EMBO J       Date:  2006-09-14       Impact factor: 11.598

3.  Blastomyces dermatitidis serine protease dipeptidyl peptidase IVA (DppIVA) cleaves ELR+ CXC chemokines altering their effects on neutrophils.

Authors:  Jenna Lorenzini; J Scott Fites; Jeniel Nett; Bruce S Klein
Journal:  Cell Microbiol       Date:  2017-05-30       Impact factor: 3.715

4.  CXCL1/MGSA Is a Novel Glycosaminoglycan (GAG)-binding Chemokine: STRUCTURAL EVIDENCE FOR TWO DISTINCT NON-OVERLAPPING BINDING DOMAINS.

Authors:  Krishna Mohan Sepuru; Krishna Rajarathnam
Journal:  J Biol Chem       Date:  2015-12-31       Impact factor: 5.157

5.  The LD78beta isoform of MIP-1alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine.

Authors:  P Menten; S Struyf; E Schutyser; A Wuyts; E De Clercq; D Schols; P Proost; J Van Damme
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

6.  Platelet microbicidal protein 1: structural themes of a multifunctional antimicrobial peptide.

Authors:  Nannette Y Yount; Kimberly D Gank; Yan Qiong Xiong; Arnold S Bayer; Thomas Pender; William H Welch; Michael R Yeaman
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

7.  The LD78beta isoform of MIP-1alpha is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages.

Authors:  S Aquaro; P Menten; S Struyf; P Proost; J Van Damme; E De Clercq; D Schols
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

8.  Isolation and biochemical characterization of LEAP-2, a novel blood peptide expressed in the liver.

Authors:  Alexander Krause; Rannar Sillard; Burkhard Kleemeier; Enno Klüver; Erik Maronde; José Ramon Conejo-García; Wolf Georg Forssmann; Peter Schulz-Knappe; Michael C Nehls; Frank Wattler; Sigrid Wattler; Knut Adermann
Journal:  Protein Sci       Date:  2003-01       Impact factor: 6.725

9.  Identification of Novel Natural Substrates of Fibroblast Activation Protein-alpha by Differential Degradomics and Proteomics.

Authors:  Hui Emma Zhang; Elizabeth J Hamson; Maria Magdalena Koczorowska; Stefan Tholen; Sumaiya Chowdhury; Charles G Bailey; Angelina J Lay; Stephen M Twigg; Quintin Lee; Ben Roediger; Martin L Biniossek; Matthew B O'Rourke; Geoffrey W McCaughan; Fiona M Keane; Oliver Schilling; Mark D Gorrell
Journal:  Mol Cell Proteomics       Date:  2018-09-26       Impact factor: 5.911

10.  Elucidating Proteoform Dynamics Underlying the Senescence Associated Secretory Phenotype.

Authors:  Peter F Doubleday; Luca Fornelli; Neil L Kelleher
Journal:  J Proteome Res       Date:  2020-01-28       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.